278 related articles for article (PubMed ID: 15641090)
1. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
[TBL] [Abstract][Full Text] [Related]
2. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
6. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
7. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
[TBL] [Abstract][Full Text] [Related]
8. An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells.
Härle P; Pongratz G; Albrecht J; Tarner IH; Straub RH
Arthritis Rheum; 2008 Aug; 58(8):2347-55. PubMed ID: 18668589
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
13. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts.
Ohata J; Miura T; Johnson TA; Hori S; Ziegler SF; Kohsaka H
Arthritis Rheum; 2007 Sep; 56(9):2947-56. PubMed ID: 17763426
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.
Ma Y; Thornton S; Duwel LE; Boivin GP; Giannini EH; Leiden JM; Bluestone JA; Hirsch R
J Immunol; 1998 Aug; 161(3):1516-24. PubMed ID: 9686619
[TBL] [Abstract][Full Text] [Related]
19. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
Glatigny S; Blaton MA; Mencher SK; Mistou S; Lucas B; Fournier C; Wang LG; Chiocchia G
Eur J Immunol; 2010 Feb; 40(2):460-9. PubMed ID: 20077403
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
